Sage Group News

Sage Group Represents Solvotrin to License Their Novel ActiveIronTM Product Portfolio

Sage Group is working with Solvotrin Therapeutics (“Solvotrin”), based in Cork, Ireland. Solvotrin is a drug development company focused on optimising established therapies, vitamins and minerals using innovative science to deliver value for significant unmet clinical needs. Solvotrin are seeking both licensing and collaboration partners for Solvotrin, to accelerate commercial rollout of their lead product Active IronTM in Europe initially and globally in the future, particularly in the USA; and to facilitate development of the next product in their pipeline for Rx. Solvotrin has launched its first product, Active IronTM, into the OTC market for Iron deficiency, initially with Walgreens Boot

Anapa Biotech Announces The Launch of Its Groundbreaking MeltPlex® Technology for Multiplexed Nuclei

Copenhagen, Denmark, 2 August 2018 – Anapa Biotech (“Anapa”; is a Copenhagen - based company with novel intellectual property and a first-in-class approach to ultrahigh performance multiplexing for molecular diagnostic assays. Following a strategic review and four years of technical development and IP filing, Anapa is pleased to announce that it is working with The Sage Group to seek one or more commercial partners, or an aquirer, for its newly launched MeltPlex® technology. This offers a new dimension of high multiplex capability for the molecular diagnostics field. Despite developments in conventional PCR, the complexity of multiplex Real Time PCR is still limited due to